Screener
Emergent Biosolutions EBS Q2 2025 earnings
Reported August 6, 2025 · After market close
Revenue$140.9MMiss by $62.8M
EPS$0.16Beat by $0.42
Revenue estimate$203.7M
EPS estimate-$0.26
Next report
Nov 4, 2026 (in 2 months)Revenue estimate$123.2M
EPS estimate-$0.37
Valuation & ratios
Segments
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Emergent Biosolutions report Q2 2025 earnings?
- Emergent Biosolutions (EBS) reported Q2 2025 earnings on August 6, 2025 after market close.
- What were Emergent Biosolutions's Q2 2025 revenue and EPS?
- Emergent Biosolutions reported revenue of $140.9M and eps of $0.16 for Q2 2025.
- Did Emergent Biosolutions beat estimates in Q2 2025?
- Revenue missed the consensus estimate of $203.7M by $62.8M. EPS beat the consensus estimate of $-0.26 by $0.42.
- How did Emergent Biosolutions's Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 44.7% from $254.7M a year earlier.
- Where can I find Emergent Biosolutions's Q2 2025 SEC filings?
- You can read the 8-K earnings release (0001367644-25-000179) and the 10-Q periodic report (0001367644-25-000181) directly on SEC EDGAR. The filing index links above go to sec.gov.
